Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
NEWPHARMA.DK ApS
APS
Dissolved
CVR 31431824
Sømarksvej 11, 2900
Hellerup
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2008 · 18 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
NEWPHARMA.DK ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
1M
1M
1M
0M
0M
2012: 0M
0M
2012
2013: 1M
1M
2013
2014: 0M (-100% vs 2013)
0M
-100%
2014
EBITDA
DKK millions
1M
1M
1M
0M
0M
2012: 0M
0M
2012
2013: 1M
1M
2013
2014: 0M (-100% vs 2013)
0M
-100%
2014
Income statement
DKK thousands
Item
2014
2013
2012
Gross profit
447
1.134
393
Staff expenses
-0
-0
-0
EBITDA
447
1.134
393
Depreciation & amort.
-4
-0
-0
EBIT
443
1.134
393
Net financials
755
26
-117
Profit before tax
1.198
1.160
—
Tax
292
139
113
Net profit
906
1.020
164
Balance sheet
DKK thousands
Item
2014
2013
2012
Total assets
3.166
2.115
1.009
Equity
2.546
1.639
—
Long-term debt
471
136
118
Short-term debt
149
339
190
Total debt
620
475
307
Financial ratios
5-year trend
EBITDA margin (of gross profit)
100,0 %
This company
2012
2014
Equity ratio
80,4 %
This company
38,2 %
Market median
This company
Market median
110% above market
2012
2014
Return on equity
35,6 %
This company
18,4 %
Market median
This company
Market median
93% above market
2012
2014
Net profit margin (of gross profit)
202,6 %
This company
2012
2014
Asset turnover (of gross profit)
0,14×
This company
2012
2014
Debt / equity
0,24×
This company
0,62×
Market median
This company
Market median
61% below market
2012
2014
Annual reports & filings
Annual report 2014
Filed via CVR / Virk · Period 2013-10-01 – 2014-06-30
View
PDF
Annual report 2013
Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
View
PDF
Annual report 2012
Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
View
PDF
More on NEWPHARMA.DK ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
